ImmunoScape
Developer of an immune profiling system and analytical tools designed to support immunotherapy clinical development. The company's tools offer immune cell profiling technologies, antigen-specific T-ce...
Valuation
$80.8M
Latest known
Share Price
N/A
Total Raised
$60.4M
Last Round
N/A